Please try another search
Amkor Technology, Inc. (NASDAQ:AMKR) recently announced proposed offering of senior notes aggregating $525 million in a private placement. The notes carry an interest rate of 6.625%, which will be...
Northrop Grumman Corp. (NYSE:NOC) recently clinched a foreign military sales (FMS) contract for procuring two complete battery sets of Integrated Air and Missile Defense Battle Command System (IBCS)...
Evolent Health (EVH) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.04 per share a year ago. These figures are...
VMware (VMW) came out with quarterly earnings of $1.98 per share, beating the Zacks Consensus Estimate of $1.87 per share. This compares to earnings of $1.68 per share a year ago. These figures are...
Enphase Energy (ENPH) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.01 per share a year ago. These...
Per Reuters, Fiat Chrysler Automobiles N.V. (NYSE:FCAU) will recall approximately 965,000 gasoline vehicles that don’t comply with U.S. emission standards. The flawed vehicles are from the...
MongoDB (NASDAQ:MDB) reported fourth-quarter fiscal 2019 adjusted loss of 17 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 38 cents and year-ago quarter’s...
Fortress Biotech (FBIO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is...
Huron Consulting (HURN) came out with quarterly earnings of $0.66 per share, missing the Zacks Consensus Estimate of $0.68 per share. This compares to earnings of $0.68 per share a year ago. These...
Investors might want to bet on Empire State Realty Trust (ESRT), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces...
Webster Financial (NYSE:WBS) seems to be a wise investment option now based on its underlying strength and earnings growth prospects. The factors that indicate the stock’s upside potential...
Corbus Pharmaceuticals (CRBP) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings...
Roche (OTC:RHHBY) announced that the European Commission (EC) has approved a label expansion of hemophilia drug, Hemlibra (emicizumab).The drug is now approved for routine prophylaxis of bleeding...
Dividend investing is in vogue once again given rounds of weak data across the globe that have renewed global growth concerns. Additionally, a warning from the top American trade negotiator that...
Exxon Mobil Corporation (NYSE:XOM) is thinking of exploring Israel as an oil and natural gas destination, according to Reuters. With this, the integrated player will be the first energy giant...